95064 ⎘
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems; Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
Sub-classes:CANNABICHROMENE DERIVATIVES AND USE THEREOF
#2HEMICYANINE PUSH-PULL DYES BASED ON CHROMENE ELECTRON DONORS
#3Substitution at the Central Position of Heptamethine Dyes By Aryllithium Addition for Improved Fluorophores
#4PI3K INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
#5COMPOUNDS FOR THE TREATMENT OF A CENTRAL NERVOUS SYSTEM DISEASE OR DISORDER
#6CHROMENE DERIVATIVES AS INHIBITORS OF TCR-NCK INTERACTION
#7SYSTEM AND COMPUTER METHOD FOR TRADING A COMMODITY WITH CARRY COSTS
#8METHOD FOR PRODUCING HETEROCYCLIDENE ACETAMIDE DERIVATIVE
#9Cannabichromene Derivatives And Use Thereof
#10NANOCRYSTALLINE COMPLEX, PREPARATION METHOD THEREFOR, AND USE THEREOF
#11METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF
#12PROCESS FOR PREPARING HISTONE DEMETHYLASE INHIBITORS
#13COMPOUNDS FOR THE TREATMENT OF A CENTRAL NERVOUS SYSTEM DISEASE OR DISORDER
#14SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS
#15PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
#16CANNABINOIDS FROM SUBSTITUTED RESORCINOL CARBOXYLIC ACIDS
#17N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF
#18CANNABICHROMENE DERIVATIVES AND METHODS FOR MAKING AND USING THE SAME
#19PROCESS FOR THE BIOBASED SYNTHESIS OF SCHWEINFURTHINS G, K AND R
#20ANTI-INFLAMMATORY CARBOXAMIDE DERIVATIVES
#21NOVEL ANTI-FIBROTIC DRUGS
#22Compounds and methods for inhibiting CYP26 enzymes
#23PERFLUORINATED AMIDE SALTS AND THEIR USES AS IONIC CONDUCTING MATERIALS
#24Chromene derivatives as inhibitors of TCR-Nck interaction
#25Polymerase inhibitors and related compositions and methods
#26Pharmaceutical Products Based on Cannabinoid Acid Esters
#27Isoflavonoid compositions and methods for the treatment of cancer
#28RAPID CONSTRUCTION OF TETRALIN, CHROMANE, AND INDANE MOTIFS VIA CYCLATIVE C-H/C-H COUPLING: FOUR-STEP TOTAL SYNTHESIS OF (±)-RUSSUJAPONOL F
#29NOVEL GUANIDINE DERIVATIVE AND METHOD FOR PRODUCING SAME
#30EXTRACTION OF CANNABINOIDS FROM WET BIOMASS
#31ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
#32RAR-ALPHA COMPOUNDS FOR INFLAMMATORY DISEASE AND MALE CONTRACEPTION
#33SUBSTITUTED CHROMANES, ANALOGS THEREOF, AND METHODS OF USE AND SYNTHESIS
#34CHROMANOL, QUINONE OR HYDROQUINONE COMPOUNDS FOR TREATMENT OF SEPSIS
#35Flavan-3-ol analogs and anti-inflammatory activity
#36ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
#37METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS
#38A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE NANOCARRIERS, METHODS OF MAKING AND USING THEREOF
#39TWO-PHOTON FLUORESCENT PROBE COMPOUND SELECTIVE FOR AMYLOID BETA PLAQUES AND METHOD FOR IMAGING AMYLOID BETA PLAQUES USING SAME
#40Polymerase inhibitors and related compositions and methods
#41PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS
#42γ-diketones as Wnt/β-catenin signaling pathway activators
#43PROCESS FOR PREPARING CHROMAN COMPOUNDS
#44COMPOUNDS AS MODULATORS OF TLR2 SIGNALING
#45TOCOPHEROL DERIVATIVES AND METHODS OF USE
#46Substituted bicyclic compounds
#47CANNABICHROMENE COMPOSITIONS AND METHODS OF SYNTHESIZING CANNABICHROMENE
#48METHOD FOR SYNTHESIZING 2-((6-(HYDROXYMETHYL)CHROMENE-5-YL)OXY)-1-PHENYLETHANONE DERIVATIVE
#49CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF PREPARATION THEREOF
#50PRODUCTION OF CANNABINOIDS
#51CANNABICHROMENE-O-ACETATE SYNTHESIS, COMPOSITIONS, AND METHODS OF USE
#52COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN
#53Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related Disorders
#54Process for the differential solubility-driven asymmetric transformation of substituted 2H-chromene-3-carboxylic acids
#55BIARYL DERIVATIVE AS GPR120 AGONIST
#56Chromene derivatives as inhibitors of TCR-Nck interaction
#57NEBIVOLOL SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF
#58Method for producing heterocyclidene acetamide derivative
#59CANNABINOID ANALOGS AND METHODS FOR THEIR PREPARATION
#60NEW ANTHELMINTIC COMPOUNDS
#61HETEROCYCLYL POLYMETHINE IR CHROMOPHORES
#62Isoflavonoid compositions and methods for the treatment of cancer
#63Synthesis of chromanol derivatives
#64α,β-unsaturated amide compound
#65Compounds and methods for inhibiting CYP26 enzymes
#66Chemical Compounds as ATF-4 Pathway Inhibitors
#67Probucol derivative, preparation method therefor and use thereof
#68NOVEL USE OF SUBSTITUTED CHROMAN-6-OLS
#69Compounds as modulators of TLR2 signaling
#70Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose
#71Methods for treating protozoan infections
#72Substituted chromanes, analogs thereof, and methods of use and synthesis
#73Isoflavonoid compounds and methods for the treatment of cancer
#74Compounds and methods for inhibiting CYP26 enzymes
#75Chromene derivatives as inhibitors of TCR-Nck interaction
#76Process for the transition metal catalyzed cyanation of aryl/vinyl halides
#77Methods for treating protozoan infections
#78Substituted bicyclic compounds
#79Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting
#80Gamma-diketones as wnt/β-catenin signaling pathway activators
#81Polymerase inhibitors and related compositions and methods
#82Synthesis of phytocannabinoids including a decarboxylation step
#83Compounds for inhibition of α4β7 integrin
#84Coumarin oxime ester compounds, preparation and use thereof
#85Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose
#86Chemical method of producing SMTP groups or SMTP-7 and intermediates used in the method
#87Isoflavonoid compositions and methods for the treatment of cancer
#88Methods for treating protozoan infections
#89Nebivolol synthesis method and intermediate compound thereof
#90Methods for treating protozoan infections
#91Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting
#92Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
#93Chromene derivatives as inhibitors of TCR-NCK interaction
#94Glucosylceramide synthase inhibitors for the treatment of diseases
#95DNA primase and gyrase inhibitors
#96Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same
#97Dual NAV1.2/5HT2a inhibitors for treating CNS disorders
#98Modulators of ATP-binding cassette transporters
#99ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
#1004-sulfur pentafluoride phenol compound and preparation method therefor, and preparation method for sulfur pentafluoride substituted benzopyran compound
#101Substituted bicyclic compounds
#102γ-diketones as Wnt/β-catenin signaling pathway activators
#103Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals
#104Process for the synthesis of intermediates of Nebivolol
#105Crystal of a heterocyclidene acetamide derivative
#106Compositions favoring wound repair
#107Aryl sulfonamides as BLT1 antagonists
#108MOST EFFECTIVE PROCESS FOR BASE-FREE PREPARATION OF KETONE INTERMEDIATES USABLE FOR MANUFACTURE OF NEBIVOLOL
#109Nitroalkene Trolox Derivatives and Methods of Use Thereof In The Treatment And Prevention of Inflammation Related Conditions
#110TOCOPHEROL DERIVATIVES AND METHODS OF USE
#111Isoflavonoid compositions and methods for the treatment of cancer
#112SecA INHIBITORS AND METHODS OF MAKING AND USING THEREOF
#113Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#114Urea derivative or pharmacologically acceptable salt thereof
#115Phenol derivatives to treat cancer
#116Nebivolol synthesis method and intermediate compound thereof
#117Functionalised benzopyran compounds and use thereof
#118Tocopherol and tocopheryl quinone derivatives as correctors of lysosomal storage disorders
#119Glutathione-cleavable prodrug and methods of use thereof
#120Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals
#121Nitroalkene trolox derivatives and methods of use thereof in the treatment and prevention of inflammation related conditions
#122Amination and hydroxylation of arylmetal compounds
#123Biaryl derivative as GPR120 agonist
#124Isoflavonoid compositions and methods for the treatment of cancer
#125Modulators of cystic fibrosis transmembrane conductance regulator protein
#126Substituted bicyclic compounds
#127Methods for treating protozoan infections
#128Synthesis of isoflavanes and intermediates thereof
#129PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2-(1-HYDROXY-ALKYL)-CHROMEN-4-ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS
#130γ-diketones as Wnt/β-catenin signaling pathway activators
#131ORGANIC REACTIONS CARRIED OUT IN AQUEOUS SOLUTION IN THE PRESENCE OF A HYDROXYALKYL(ALKYL)CELLULOSE OR AN ALKYLCELLULOSE
#132Method of isolating blue anthocyanin fractions
#133Method for producing nebivolol hydrochloride of high purity
#134Fused (hetero)cyclic compounds as S1P modulators
#1356-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives
#136ANTIMICROBIALS FROM AN EPIGENETICS BASED FUNGAL METABOLITE SCREENING PROGRAM
#137Substituted bicyclic compounds
#138Histone deacetylase inhibitors and compositions and methods of use thereof
#139SUBSTITUTED 3-PHENYLPROPYLAMINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISEASES AND DISORDERS
#140Deuterated benzopyran compounds and the use in the treatment of pain and inflammation
#141N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
#142Compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient
#143No-releasing nitrooxy-chromene conjugates
#144Functionalised benzopyran compounds and use thereof
#145MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#146N-substituted benzamides and methods of use thereof
#147Deuterated benzopyran compounds and application thereof
#148FLUOROGENIC PROTECTING GROUP
#149Chromene derivatives as inhibitors of TCR-Nck interaction
#150Chromene derivatives substituted by alkoxide as inhibitors of the TCR-Nck interaction
#151Monomer, organic layer composition, organic layer, and method of forming patterns
#152Glucosylceramide synthase inhibitors for the treatment of diseases
#153Processes for preparing medicaments for the treatment of cardiovascular diseases and intermediates for use therein
#154Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage Disorders
#155Method for preparing benzopyran compound and application thereof in treating pulmonary fibrosis
#156Compositions and methods for repelling blood-sucking and biting insects, ticks and mites
#157Inhibitors of viral replication, their process of preparation and their therapeutical uses
#158Chromane and chromene derivatives and their use as CRAC modulators
#159Synthetic analogues of xanthohumol
#160Substituted bicyclic compounds
#161S-nitrosoglutathione reductase inhibitors
#162Method of isolating blue anthocyanin fractions
#163Therapeutic agent for ocular disease
#164Substituted chroman compounds as calcium sensing receptor modulators
#165Salts and crystal forms
#166Substituted chroman derivatives, medicaments and use in therapy
#167(6R,10R)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundec-5-en-2-one or 6,10-dimetylundeca-5,9-dien-2-one
#168Using mixtures of E/Z isomers to obtain quantitatively specific products by combined asymmetric hydrogenations
#169Benzyl sulfonamide compounds useful as MoGAT-2 inhibitors
#1706-substituted phenoxychroman carboxylic acid derivatives
#171Most effective process for base-free preparation of ketone intermediates usable for manufacture of nebivolol
#172Histone deacetylase inhibitors and compositions and methods of use thereof
#173NO-RELEASING GUANIDINE-CHROMENE CONJUGATES
#174NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT
#175SecA inhibitors and methods of making and using thereof
#176Deuterated benzopyran compounds and application thereof
#177Bicyclic compound
#178Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
#179Methods for making tocoflexols and analogues thereof
#180Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#181Compositions and products containing S-equol, and methods for their making
#182Substituted chroman compounds as calcium sensing receptor modulators
#183Chroman derivative
#184Compounds and compositions for use in augmentation of glucose
#185Process for the production of 4-substituted chromanes via gold catalysis
#186Fluorinated estrogen receptor modulators and uses thereof
#187Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
#188Monomer for hardmask composition and hardmask composition including the monomer and method of forming patterns using the hardmask composition
#189Two-photon absorbing compound with methods of synthesis and use
#190Cajanine structure analogous compound, preparation method and use
#191Estrogen receptor modulators and uses thereof
#192Modulators of ATP-binding cassette transporters
#193Inhibiting G protein coupled receptor 6 kinase polypeptides
#194S-nitrosoglutathione reductase inhibitors
#195Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
#196Pharmaceutical composition
#197HIV replication inhibitor
#198γ-diketones as WNT/β-catenin signaling pathway activators
#199CHROMENE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
#200Isoflavonoid compounds and methods for the treatment of cancer
#201Agents and methods for treating ischemic and other diseases
#2026-substituted phenoxychroman carboxylic acid derivatives
#203INHIBITORS OF BACTERIAL TYPE III SECRETION SYSTEM
#204Process for the cyclodehydration of diols and use thereof for the manufacturing of ambrafuran and other cycloether derivatives
#205Substituted chroman derivatives, medicaments and use in therapy
#206Chroman derivatives, medicaments and use in therapy
#207GPR120 RECEPTOR AGONISTS AND USES THEREOF
#208Aromatic amides as potentiators of bioefficacy of anti-infective drugs
#209Process for autocatalytic esterification of fatty acids
#210Inhibitors of viral replication, their process of preparation and their therapeutical uses
#2116-substituted phenoxychroman carboxylic acid derivatives
#212Chromene derivatives
#213Fulvene and fulvalene analogs and their use in treating cancers
#214N-substituted benzamides and methods of use thereof
#215N-substituted benzamides and methods of use thereof
#216Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
#217Process for the preparation of nebivolol
#218Method for obtaining phytosterols and/or tocopherols from residue of a distillation of the esters of vegetable oils, preferably from distillation residue from a transesterification of vegetable oils
#219Process for the preparation of nebivolol
#220Isoflavonoid compositions and methods for the treatment of cancer
#221TREATMENT OF MITOCHONDRIAL DISEASES
#222Compounds and Mixtures Influencing Inflammatory States
#223Compounds and mixtures for influencing inflammatory states
#224ACYLATIONS IN MICRO REACTION SYSTEMS
#225Vitamin E conjugates, and their uses as antioxidants and prodrug delivery vehicles
#226Naphth-2-ylacetic acid derivatives to treat AIDS
#227Ruthenium complexes for use in olefin metathesis
#228Hypoxia inducible factor-1 pathway inhibitors and uses as anticancer and imaging agents
#229Method for enantioselective hydrogenation of chromenes
#230Inhibitors of HIF and angiogenesis
#231Fungicide N-cycloalkyl-N-bicyclimethylene-carboxamide derivatives
#232Modulators of ATP-binding cassette transporters
#233Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
#234Fused bicyclic compound
#235METHOD FOR PRODUCING NEBIVOLOL
#236Heterocyclic CETP inhibitors
#237Process for the preparation of nebivolol
#238S-nitrosoglutathione reductase inhibitors
#239Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
#240Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#241Chroman derivatives, medicaments and use in therapy
#242Compositions and products containing R-equol, and methods for their making
#243Methods for synthesizing glycinols, glyceollins I and II and isoflavenes and chromanes using a Wittig reaction, and compositions made therewith
#244Substituted chroman derivatives, medicaments and use in therapy
#245Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound
#246Chroman derivatives
#247Composition comprising the extract of Bunge or the compounds isolated from the same for preventing and treating lipid metabolism disorder
#248COMPOSITIONS AND PRODUCTS CONTAINING S-EQUOL, AND METHODS FOR THEIR MAKING
#249Antagonists of the TRPV1 receptor and uses thereof
#250Method for enantioselective hydrogenation of chromenes
#251Selective estrogen receptor modulator
#252Chroman derivatives, medicaments and use in therapy
#253Compositions and products containing S-equol, and methods for their making
#254GPR120 receptor agonists and uses thereof
#255Fungicide N-cycloalkyl-N-bicyclimethylene-carboxamide derivatives
#256Method for preparing nebivolol
#257Process for preparing Nebivolol
#258BICYCLIC ACYLGUANIDINE DERIVATIVE
#259Process for preparing nebivolol
#260Compound having hydrocoumarin skeleton, liquid crystal compostition, and liquid crystal display device
#2612-SUBSTITUTED ISOFLAVONOID COMPOUNDS, MEDICAMENTS AND USES
#262Design, synthesis and functional characterization of rottlerin analogs
#263Chromene modulators of chemokine receptor activity
#2646-substituted phenoxychroman carboxylic acid derivatives
#265MODULATORS OF DOPAMINE NEUROTRANSMISSION
#266Modulators of dopamine neurotransmission
#267HYDROXYLATED NEBIVOLOL METABOLITES
#268Process for preparing nebivolol
#269Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
#270Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
#271Intermediate compounds and processes for the preparation of 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran
#272Processes for preparing isoflavonoids using 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran as a starting material
#273Monomethine dyes
#274ISOFLAVONE METABOLITES
#275Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#276Heterocyclic CETP inhibitors
#277Process for Preparing Chroman Derivatives
#278Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity
#279Fused bicyclic compound
#280GPR120 receptor agonists and uses thereof
#281Modulators of ATP-binding cassette transporters
#282Small molecule Bcl-Xl/Bcl-2 binding inhibitors
#283PREVENTION AND REVERSAL OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
#284Piperidine and piperazine derivatives
#285Compositions and products containing S-equol, and methods for their making
#286Antidiabetic bicyclic compounds
#287Chroman compounds
#288Potassium channel blockers
#289Process for preparing Nebivolol
#290Method for enantioselective hydrogenation of chromenes
#291Process for preparing nebivolol
#292N-(3-AMINO-2-HYDROXY-PROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS
#293Catalytic hydrogenation of ene-carbamates
#294NOVEL CHROMENE AND THIOCHROMENE CARBOXAMIDE DERIVATIVES, METHODS FOR PREPARING SAME AND THERAPEUTIC APPLICATIONS OF SAME
#295Selective estrogen receptor modulator
#296Substituted chroman derivatives, medicaments and use in therapy
#297ISOFLAVAN AND ISOFLAVENE COMPOUNDS AND THEIR USE AS ANGIOGENESIS INHIBITORS
#298Method for preparing 2,5,7,8-tetramethyl-2-(2′-carboxyethyl)-6-acetoxychroman-precursor- α-CEHC precursor
#299Process for the production of benzopyran-2-ol derivatives
#300Modulators of ATP-binding cassette transporters